ASH Annual Meeting and Exposition 2021

The 2021 American Society of Hematology Annual Meeting (ASH) is taking place December 11-14, virtually and in-person in Atlanta, Georgia.

Look out for coverage of the meeting and click here to learn more about the 2021 ASH Annual Meeting.

Anti-BCMA CAR T-Cell Therapy CT103A Provides Rapid, Durable Responses

In a single-arm phase I/II study, infusion with CT103A, a novel fully human B-cell maturation antigen (BCMA)-targeted chimeric antigen...

Tisa-Cel Found Noninferior to Standard of Care in Relapsed/Refractory Aggressive B-Cell NHL

According to results from the phase III BELINDA trial, patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma (NHL) who received...

ZUMA-7: Benefits of Axi-Cel Persist Over Current Standard of Care in Aggressive B-Cell Lymphoma

The chimeric antigen receptor (CAR) T-cell therapy axicabtagene ciloleucel (axi-cel) demonstrated significant and clinically meaningful improvement in event-free survival...

Curated Journal Abstracts

Advertisement
Advertisement